Results 31 to 40 of about 3,309 (157)

Relationship between serum BDNF levels and cognitive functions, cortisol levels in depressive disorder?

open access: yesPsychiatry and Behavioral Sciences, 2012
Objective: The objective of this study was to examine the relationship between the serum BDNF levels in depressive disorder patients and cognitive functions along with cortisol levels.
Gulfizar Sozeri-Varma   +5 more
doaj   +1 more source

Psikiyatri Hemşireliğinin Geleceği

open access: yes, 2015
Mersin Üniversitesi Sağlık Bilimleri ...
Yılmaz, Mualla, Özcan, Ayşe
openaire   +2 more sources

THE EFFICACY AND SAFETY OF HALOPERIDOL AND RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: In this study were aimed to compare the efficacy and safety of typical antipsychotic haloperidol and atypical antipsychotic risperidone in patients with schizophrenia.
Servet Ebrinç   +4 more
doaj  

Lived experience in research and publishing

open access: yesKlinik Psikiyatri Dergisi, 2023
Deniz Ceylan
doaj   +1 more source

Bir devlet hastanesinde psikiyatri dışı benzodiazepin kullanımı

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Bir devlet hastanesinde psikiyatri dışı benzodiazepin kullanımı Hastane içinde psikiyatri kliniği dışındaki servislerin, benzodiazepin kullanımı/kötüye kullanımını araştırmak amacıyla, İzmir Devlet Hastanesinin dahili ve cerrahi tıp servislerinin ...
İlkin İçelli
doaj  

Left frontal lobe N-acetylaspartate levels in patients with deficit schizophrenia

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: This study aimed to detect the N-acetylaspartate levels of the left frontal lobe in patients with deficit schizophrenia. Method: Schizophrenia was diagnosed using the DSM-IV criteria.
Barbaros Özdemir   +3 more
doaj  

THE COMPARISON OF EFFICACY AND SAFETY OF NEFAZODONE AND AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Nefazodone is a novel antidepressant whose efficacy has been demonstrated in the treatment of depression. The present study was planned to evaluate the efficiency and side effect profile of nefazodone, used recently in our country is ...
Murad Atmaca   +5 more
doaj  

Efficacy and safety of amisulpride treatment in schizophrenia: Comparison with haloperidol

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Amisulpride is a novel atypical antipsychotic with preferential affinity for presynaptic dopaminergic D2 and D3 receptors. There have been no clinical studies conducted with amisulpride in schizophrenia in Turkey.
Servet Ebrinç   +6 more
doaj  

THE EFFICACY AND SAFETY OF VENLAFAXINE İN TREATMENT OF MAJOR DEPRESSION

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Venlafaxine, a novel antidepressant drug for Turkish population , there are both norepinephrine and serotonin reuptake inhibitory effects. An open study was performed to evaluate the antidepressant efficacy and safety of venlafaxine. Fourthy male and 60
Servet Ebrinç   +6 more
doaj  

Value of early symptomatic response to antidepressant treatment in predicting treatment response in major depression

open access: yesPsychiatry and Behavioral Sciences, 2015
Objective: Is it possible to predict the antidepressant treatment response in patients with major depressive disorder? For the antidepressant treatment, the common belief is to wait 6 weeks for deciding its effectiveness. It seem to be crucial to shorten
Sedar Bulut   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy